allegations that it knowingly caused the submission of false claims to Medicare and other federal health care programs by paying kickbacks to healthcare providers to induce prescriptions of Trintellix, an antidepressant medication that Takeda marketed and sold to treat major depressive disorder.
“The Department of Justice is committed to vigorously pursuing violations of the False Claims Act arising from illegal kickbacks,” said Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division. “Such conduct can erode the trust that patients place in their healthcare providers and lead to higher drug costs for American taxpayers.”
“This settlement demonstrates the continued commitment of my office to ensure that patients’ best interests remain paramount,” said Eric Grant, U.S. Attorney for the Eastern District of California. “Prescribing decisions should not be influenced by drug companies’ payments or side perks made available to physicians.”
“Alleged kickback schemes such as those described in this matter undermine the trust that patients place in their providers and federal health care programs,” said Acting Deputy Inspector General for Investigations Scott J. Lampert of the U.S. Department of Health and Human Services, Office of Inspector General (HHS OIG). “This settlement underscores that HHS-OIG, together with our law enforcement partners, will investigate and hold accountable entities that attempt to disguise purported honoraria or other...
Image: Facebook/SAPS The IDAC has rubbished rumours that it has a J50 warrant of arrest for KZN provincial police commissioner Lieutenant-General Nhlanhla Mkhwanazi as “false”. This comes after re...